Policy · 2026-04-08
The Evolving Kratom Policy Landscape: Bans, Scheduling, and Consumer Protection Acts
Source: Rockefeller Institute of Government
Why it matters
This comprehensive policy analysis maps the three primary legislative approaches states are pursuing—outright bans, controlled substance scheduling, and consumer protection acts—providing critical context for the rapidly evolving kratom regulatory landscape.
The big picture
Nearly every state introduced kratom legislation in the 2025-26 session, with approaches diverging sharply. Some states opt for bans (Wisconsin, Indiana, Alabama); others schedule 7-OH as Schedule I (Kansas, Connecticut); still others establish consumer protection acts with testing, labeling, and age restrictions. Recent state wins include Connecticut's ban and Nebraska's consumer protection act.
Key findings
- Connecticut and Kansas recently enacted kratom bans or scheduling; Ohio and other states pursuing synthetic-specific restrictions
- Three primary policy models: full bans, controlled substance scheduling (often Schedule I), and consumer protection acts with testing/labeling requirements
- Consumer protection acts typically include age restrictions (18-21+), independent lab testing, alkaloid concentration limits (~2% 7-OH), and labeling requirements
- States like Rhode Island reversed prior bans, implementing regulatory frameworks similar to cannabis licensing
- Competing approaches reflect national debate: safety warnings vs. regulated access for pain management and opioid withdrawal support
What they say
The states have become the primary policymakers. For those states looking to act on kratom, three primary policy preferences have emerged: ban, schedule as a controlled substance, or create a commercial market with limitations and regulations. — Rockefeller Institute analysis
Bottom line
States are pursuing three distinct regulatory strategies—bans, controlled substance scheduling, and consumer protection acts—reflecting fundamental disagreement over whether kratom poses unacceptable risks or offers potential benefits under regulation.